Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Database

BACKGROUND: Fostemsavir, a prodrug of the gp120-directed attachment inhibitor temsavir, is indicated for use in heavily treatment-experienced individuals with MDR HIV-1. Reduced susceptibility to temsavir in the clinic maps to discrete changes at amino acid positions in gp160: S375, M426, M434 and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gartland, Margaret, Arnoult, Eric, Foley, Brian T, Lataillade, Max, Ackerman, Peter, Llamoso, Cyril, Krystal, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561262/
https://www.ncbi.nlm.nih.gov/pubmed/34297843
http://dx.doi.org/10.1093/jac/dkab257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561262/
https://www.ncbi.nlm.nih.gov/pubmed/34297843
http://dx.doi.org/10.1093/jac/dkab257

Ejemplares similares